Dr. Selina Wray is an Alzheimer’s Research UK Senior Research Fellow at the UCL Institute of Neurology. Her research is focused on understanding the molecular mechanisms of dementia (Alzheimer’s Disease and Frontotemporal Dementia) with a particular emphasis on the tau protein. Selina received her degree in Biochemistry and Biological Chemistry from the University of Nottingham in 2004, before undertaking Ph.D. training in Dr. Diane Hanger’s laboratory at the Institute of Psychiatry, Kings College London. Selina was awarded her Ph.D. in 2008 and subsequently joined the laboratory of Professor John Hardy at UCL Institute of Neurology as an Alzheimer’s Research UK Junior Research Fellow. In 2014 Selina was awarded a Red Magazine “Woman of the Year” award in the pioneer category to recognise her contribution to research and outreach in the area of dementia.
Clinical Lead for the 100,000 Genomes
Project Cancer Programme
Senior Researcher, Institute of Cancer Research
Dr. Clare Turnbull is the Clinical Lead for Cancer Data for the Genomics England 100,000 Genomes Project. She has a Readership in Genomics at Queen Mary University London and also leads a research team at the Institute of Cancer Research, London, focused on translational studies in cancer genomics and genetic predisposition. Her main research focus has been on the genetic basis of testicular cancer and she has also published extensively on genetic susceptibility to breast, ovarian and childhood cancers. Having trained as a Clinical Geneticist, her clinical work at Guys and St Thomas’ NHS Trust focuses on management of patients and families with genetic susceptibility to cancer.
Clare undertook her preclinical training in Cambridge and qualified in medicine from Oxford University. She completed a PhD in Genetic Epidemiology and Molecular Genetics at the Institute of Cancer Research and a Masters degree in Epidemiology at the London School of Hygiene and Tropical Medicine.
Tamar (Tami) Geiger
Assistant professor, Department of Human Molecular Genetics and Biochemistry,
Sackler Faculty of Medicine, Tel Aviv University
Dr. Tamar Geiger studied biology at the Hebrew University of Jerusalem, Israel, where she also completed her master’s and doctoral degrees in biochemistry. She carried out her Ph.D. research under the supervision of Prof. Alexander Levitzki. In 2008 she moved to the laboratory of Prof. Matthias Mann at the Max Planck Institute of Biochemistry to specialize in proteomics technology and to apply it to cancer research. Tamar developed the super-SILAC technique, which enables accurate quantification of proteins in human tumor samples. In October 2011 Tamar moved back to Israel and opened her own research laboratory at the Sackler Faculty of Medicine at the Tel Aviv University. She is proceeding with clinical proteomic research of breast cancer and melanoma with emphasis on the metabolic changes that occur during cancer progression and development of proteomic techniques for cancer research and biomarker discovery.
Chief Scientific Officer, Oxitec
Simon is currently Chief Scientific Officer at Oxitec, a biotechnology company developing innovative new solutions to controlling insect pests that spread disease and damage crops. Oxitec uses advanced genetics to insert a self-limiting gene into its mosquitoes. When Oxitec mosquitos are released into the wild their offspring will inherit the self-limiting trait and so die before reaching adulthood. In this way, a local mosquito population, which may spread a disease such as Zika, Malaria, or Dengue fever, can be forced into decline.
Prior to his role at Oxitec, Simon has eighteen years of global commercial experience in biotechnology R&D in various roles at Syngenta, leading collaborative programs and delivering biotechnology products in crops for feed and fuel. Immediately prior to joining Oxitec, he was Senior Director of Research and Development Programs at Sapphire Energy, a start-up making algae-based fuel, based in San Diego, California. Simon has a BSc in biochemistry from UCL and PhD in plant molecular biology from the University of Leicester.
Senior Research Scientist and Principal Engineer, NASA’s Jet Propulsion Laboratory, California Institute of Technology
Dr. Shouleh Nikzad is a Senior Research Scientist and a Principal Engineer at NASA’s Jet Propulsion Laboratory, California Institute of Technology where she is also the Lead for the Advanced Detectors, Imaging System, and Nanoscience Group as well as the co-founder, co-Lead and Technical Director for Medical Engineering Forum at JPL. She is a founding member of the Society for Brain Mapping and Therapeutics (SBMT)’s Board of Directors who served as the President for the 2014-2015 term. Shouleh’s research interests include materials and detectors and she is passionate about extending the application of space technology to medicine.
Head and Senior Fellow, Centre on Global Health Security
Professor David L. Heymann is Head of the Centre on Global Health Security at Chatham House, London; Professor of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine and Chairman of the Board, Public Health England, UK. Previously, he was the World Health Organization’s Assistant Director-General for Health Security and Environment and Representative of the Director-General for polio eradication. From 1998 to 2003 he was Executive Director of the WHO Communicable Diseases Cluster during which he headed the global response to SARS. Before joining WHO, Professor Heymann worked for 13 years as a medical epidemiologist in sub-Saharan Africa on assignment from the US Centers for Disease Control and Prevention (CDC) where, as well as supporting ministries of health in research, he participated in the first and second outbreaks of Ebola Hemorrhagic Fever. Prior to joining CDC, Professor Heymann worked in India for two years in the WHO Smallpox Eradication Programme. He is an elected fellow of the Institute of Medicine of the National Academies (United States) and the Academy of Medical Sciences (United Kingdom) and has been awarded several public health awards. In 2009 Professor Heymann was appointed an honorary Commander of the Most Excellent Order of the British Empire (CBE) for service to global public health.
Professor Andrew Hayward
Head, Department of Infectious Disease Informatics, Farr Institute at UCL
Professor Hayward qualified in Medicine at United Medical and Dental Schools London. He was awarded a distinction for an MSc in Communicable Disease Epidemiology at the London School of Hygiene and Tropical Medicine before completing his public health training in London and Nottingham. He became a UCL Professor of Infectious Disease Epidemiology and Inclusion Health in 2014 leading a successful group focussing on acute respiratory infections, tuberculosis, hospital acquired infection, antimicrobial prescribing and resistance and infections in hard to reach groups. In 2015 he established a new Department of Infectious Disease Informatics in the new UCL Institute of Health Informatics to take advantage of the highly multidisciplinary world-class research environment and outstanding opportunities in Big Data research.
Professor Hayward plays an active role in Policy and Guideline Development through membership of the Joint Committee on Vaccination and Immunisation Influenza Subgroup and of the New and Emerging Respiratory Threats Advisory Group. He chaired the NICE national guideline development group for Tuberculosis in Underserved Groups and co-chaired the 2014-16 NICE group revising all national tuberculosis guidance. He is a trustee of the Pathway Homeless Health Charity and a member of the Research Advisory Board of the Groundswell Homeless Health Peer Advocacy charity.